adrenocortical carcinoma
Showing 1 - 25 of 49
Adrenocortical Carcinoma, ACC, Metastatic Adrenocortical Carcinoma Trial in United States (Ablative Radiotherapy, Pembrolizumab)
Recruiting
- Adrenocortical Carcinoma
- +2 more
- Ablative Radiotherapy
- Pembrolizumab
-
Basking Ridge, New Jersey
- +6 more
Sep 27, 2023
Adrenal Diseases- Laparoscopic vs. Robotic-assisted
Recruiting
- Adrenal Tumor
- +12 more
-
Olomouc, CzechiaUniversity hospital Olomouc
Sep 17, 2023
Adrenocortical Carcinoma Trial in Ann Arbor (68Ga-R8760 injection at pre-defined dose levels, 68GA-R8760 injection)
Recruiting
- Adrenocortical Carcinoma
- 68Ga-R8760 injection at pre-defined dose levels
- 68GA-R8760 injection
-
Ann Arbor, MichiganUniversity of Michigan Nuclear Medicine
Aug 11, 2023
Adrenocortical Carcinoma Trial in Brescia (Etoposide, doxorubicin, cisplatin and Mitotane plus Megestrol Acetate 160 MG,
Recruiting
- Adrenocortical Carcinoma
- Etoposide, doxorubicin, cisplatin and Mitotane plus Megestrol Acetate 160 MG
- Etoposide, doxorubicin, cisplatin and Mitotane plus Placebo
-
Brescia, ItalyAlfredo Berruti
Jun 12, 2023
The Adverse Event of Mitotane Therapy in Adrenocortical
Not yet recruiting
- Adrenocortical Carcinoma
- (no location specified)
Apr 21, 2023
Lymph Node Dissection in Surgical Management of Adrenal Cortical
Recruiting
- Adrenocortical Carcinoma
- Adrenalectomy with or without lymphadenectomy
-
Rome, ItalyFondazione Policlinico Universitario Agostino Gemelli IRCCS
Feb 28, 2023
Survival Analysis in Children and Adults Adrenocortical Cancer
Active, not recruiting
- Adrenocortical Carcinoma
-
Bethesda, MarylandNational Cancer Institute (NCI)
Jan 20, 2023
Children and Adults With Adrenocortical Cancer (ACC)
Terminated
- Adrenocortical Carcinoma
- Adrenocortical Cancer
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 13, 2023
Adrenal Vein Sampling asTool to Identify Biomarkers That Aid
Recruiting
- Adrenocortical Carcinoma
- Blood sampling.
-
Rotterdam, NetherlandsErasmus MC
Dec 14, 2022
Adrenocortical Carcinoma Trial (Camrelizumab)
Recruiting
- Adrenocortical Carcinoma
-
Chengdu, Sichuan, ChinaWest China Hospital, Sichuan University
Dec 16, 2022
Adrenocortical Carcinoma Trial in Houston (Mitotane, Pembrolizumab)
Not yet recruiting
- Adrenocortical Carcinoma
-
Houston, TexasM D Anderson Cancer Center
Nov 22, 2022
Adrenocortical Carcinoma Trial (Pembrolizumab 25 MG/ML [Keytruda])
Not yet recruiting
- Adrenocortical Carcinoma
- Pembrolizumab 25 MG/ML [Keytruda]
- (no location specified)
Sep 29, 2022
Genitourinary Cancer, Adrenocortical Carcinoma, Non-urothelial Bladder Trial in United States (Ipilimumab, Nivolumab)
Recruiting
- Genitourinary Cancer
- +7 more
-
La Jolla, California
- +5 more
Jul 5, 2022
Adrenocortical Carcinoma Trial in United States (Relacorilant, Pembrolizumab)
Recruiting
- Adrenocortical Carcinoma
-
Stanford, California
- +5 more
Jun 27, 2022
Familial Investigations of Childhood Cancer Predisposition
Recruiting
- Acute Leukemia
- +45 more
-
Memphis, TennesseeSt. Jude Children's Research Hospital
May 11, 2022
Primary Aldosteronism Due to Aldosterone Producing Adenoma, Primary Aldosteronism Due to Nodular Hyperplasia, Adrenal Cushing
Completed
- Primary Aldosteronism Due to Aldosterone Producing Adenoma
- +4 more
-
Uppsala, SwedenUppsala University Hospital
Apr 29, 2022
Serum Free Proteins in Patients With Adrenocortical Carcinoma
Active, not recruiting
- Adrenocortical Carcinoma
-
London, United KingdomKing's College Hospital NHS Foundation Trust
Apr 19, 2022
Adrenocortical Carcinoma, Peritoneal Carcinomatosis Trial in New York (Cisplatin, Sodium thiosulfate, Cytoreductive surgery)
Recruiting
- Adrenocortical Carcinoma
- Peritoneal Carcinomatosis
- Cisplatin
- +2 more
-
New York, New YorkColumbia University Medical Center
Mar 17, 2022
Adrenocortical Carcinoma, Pheochromocytoma, Paraganglioma Trial in Worldwide (EO2401)
Recruiting
- Adrenocortical Carcinoma
- +2 more
- EO2401
-
Houston, Texas
- +9 more
Dec 7, 2021
Adrenocortical Carcinoma Trial (Pembrolizumab / Lenvatinib)
Not yet recruiting
- Adrenocortical Carcinoma
- Pembrolizumab / Lenvatinib
- (no location specified)
Nov 15, 2021
Adrenal Incidentaloma, Adrenocortical Carcinoma Trial in Groningen
Recruiting
- Adrenal Incidentaloma
- Adrenocortical Carcinoma
-
Groningen, NetherlandsUniversity Medical Center Groningen
Sep 29, 2021
Adrenocortical Carcinoma, Cushing's Syndrome Trial in Wuerzburg
Recruiting
- Adrenocortical Carcinoma
- Cushing's Syndrome
-
Wuerzburg, GermanyDept. of Medicine I, University of Wuerzburg
Jun 1, 2021
German Adrenocortical Carcinoma Registry
Recruiting
- Adrenocortical Carcinoma
-
Wuerzburg, GermanyUniversity of Wuerzburg
Jun 1, 2021
Adrenal Tumors - Pathogenesis and Therapy
Recruiting
- Adrenal Tumors
- +4 more
-
Wuerzburg, GermanyUniversity of Wuerzburg
Jun 1, 2021
A Prospective Cohort Study for Patients With Adrenal Diseases
Enrolling by invitation
- Adrenal Adenoma
- +5 more
- Hormone study and Imaging study
-
Seoul, Korea, Republic ofSeoul National University Hospital
Mar 16, 2020